EBV-POSITIVE NON-HODGKIN LYMPHOMA
Clinical trials for EBV-POSITIVE NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new EBV-POSITIVE NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for EBV-POSITIVE NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase trial tests a new type of immune cell therapy for patients with EBV-positive Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard treatments. The researchers add a gene called C7R to the patient's own T cells to help them survive longer …
Matched conditions: EBV-POSITIVE NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immune cells take aim at Virus-Linked lymphomas
Disease control Recruiting nowThis study tests a new way to make immune cells (called GRALE T cells) that are trained to attack cells infected with the Epstein-Barr virus (EBV), which is linked to some lymphomas. The trial includes people with Hodgkin or non-Hodgkin lymphoma, or related diseases, whose cancer…
Matched conditions: EBV-POSITIVE NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC